Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Canning

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cell Reports|February 9, 2018
CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary FunctionPeter Canning, Kwangjin Park, João Gonçalves, et al.
Public Health Reports (Washington, D.C. : 1974)|November 2, 2021
Using Surveillance With Near-Real-Time Alerts During a Cluster of Overdoses From Fentanyl-Contaminated Crack Cocaine, Connecticut, June 2019Peter Canning, Suzanne Doyon, Sarah Ali, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2019
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compoundsAbimael Cruz-Migoni, Peter Canning, Camilo E Quevedo, et al.
Biochimie|April 10, 2012
Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidaseKarol Kaszuba, Tomasz Róg, Reinis Danne, et al.
Frontiers in Microbiology|April 19, 2024
Prophylactic treatment with PEGylated bovine IFNλ3 effectively bridges the gap in vaccine-induced immunity against FMD in cattleSarah E Attreed, Christina Silva, Monica Rodriguez-Calzada, et al.
Chemistry & Biology|September 1, 2015
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase InhibitorsPeter Canning, Qui Ruan, Tobias Schwerd, et al.
The Journal of Biological Chemistry|January 26, 2013
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligasesPeter Canning, Christopher D O Cooper, Tobias Krojer, et al.
Communications Biology|January 28, 2026
Structural insights into WRN helicase reveal conformational states and opportunities for MSI-H cancer drug discoveryCatherine T Fletcher, Abigail A Mornement, Charlotte Barrett, et al.
ACS Chemical Biology|August 1, 2013
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitorHyung-Gu Kim, Li Tan, Ellen L Weisberg, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2023
Evaluating the druggability of TrmD, a potential antibacterial target, through design and microbiological profiling of a series of potent TrmD inhibitorsAndrew J Wilkinson, Nicola Ooi, Jonathan Finlayson, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cell Reports|February 9, 2018
CDKL Family Kinases Have Evolved Distinct Structural Features and Ciliary FunctionPeter Canning, Kwangjin Park, João Gonçalves, et al.
Public Health Reports (Washington, D.C. : 1974)|November 2, 2021
Using Surveillance With Near-Real-Time Alerts During a Cluster of Overdoses From Fentanyl-Contaminated Crack Cocaine, Connecticut, June 2019Peter Canning, Suzanne Doyon, Sarah Ali, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2019
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compoundsAbimael Cruz-Migoni, Peter Canning, Camilo E Quevedo, et al.
Biochimie|April 10, 2012
Molecular dynamics, crystallography and mutagenesis studies on the substrate gating mechanism of prolyl oligopeptidaseKarol Kaszuba, Tomasz Róg, Reinis Danne, et al.
Frontiers in Microbiology|April 19, 2024
Prophylactic treatment with PEGylated bovine IFNλ3 effectively bridges the gap in vaccine-induced immunity against FMD in cattleSarah E Attreed, Christina Silva, Monica Rodriguez-Calzada, et al.
Chemistry & Biology|September 1, 2015
Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase InhibitorsPeter Canning, Qui Ruan, Tobias Schwerd, et al.
The Journal of Biological Chemistry|January 26, 2013
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligasesPeter Canning, Christopher D O Cooper, Tobias Krojer, et al.
Communications Biology|January 28, 2026
Structural insights into WRN helicase reveal conformational states and opportunities for MSI-H cancer drug discoveryCatherine T Fletcher, Abigail A Mornement, Charlotte Barrett, et al.
ACS Chemical Biology|August 1, 2013
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitorHyung-Gu Kim, Li Tan, Ellen L Weisberg, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2023
Evaluating the druggability of TrmD, a potential antibacterial target, through design and microbiological profiling of a series of potent TrmD inhibitorsAndrew J Wilkinson, Nicola Ooi, Jonathan Finlayson, et al.
Pageof 3